| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | President And CEO
1 company
Session R.A. II is a 10% Owner at Taysha Gene Therapies, Inc.. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $60.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | TSHA Taysha Gene Therapies, Inc. | 10% Owner | Sell | 85,872 | $0.71 | $60,770.73 | -0.5% | +252.9% | +238.6% | |
| Jun 23, 2023 | TSHA Taysha Gene Therapies, Inc. | 10% Owner | Sell | 28,608 | $0.70 | $20,119.13 | -0.2% | +359.1% | +348.5% | |
| Jun 21, 2023 | TSHA Taysha Gene Therapies, Inc. | 10% Owner | Sell | 434,615 | $0.71 | $307,843.98 | -2.3% | +365.6% | +294.2% | |
| Nov 23, 2021 | TSHA Taysha Gene Therapies, Inc. | President And CEO | Buy | 42,518 | $12.44 | $529,102.40 | +0.2% | -52.3% | -81.8% |